[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:dystonia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":148,"states":149},"Dystonia",23,21,[8,16,22,29,35,41,47,53,59,65,71,77,82,88,94,100,106,112,118,124,130,136,143],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07626216","Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia",[12],"Early Phase 1","RECRUITING","2026-08-26T02:18:31.944757Z","2026-06-05T00:55:50.388844Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06606574","Intrathecal Baclofen and Pediatric Dystonia",[],"2026-08-26T02:18:58.141497Z","2026-05-05T02:43:27.797968Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06554288","Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy",[26],"Phase 1","2026-08-26T02:17:12.307088Z","2026-05-05T02:35:31.746460Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04735458","Investigating Inhibitory Control Networks in Parkinson's Disease",[],"2026-08-26T02:17:36.611194Z","2026-05-05T02:43:29.402026Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT02119611","Deep Brain Stimulation Therapy in Movement Disorders",[],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:26.926624Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT01581580","Deep Brain Stimulation Surgery for Movement Disorders",[],"2026-08-26T02:17:00.709807Z","2026-05-05T02:43:26.687870Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07325175","Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia",[],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:27.666705Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05317390","Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia",[],"2026-08-26T02:18:25.327036Z","2026-05-05T02:43:28.344085Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT03428009","Dystonia Genotype-Phenotype Correlation",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.125903Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT04071847","Abbott DBS Post-Market Study of Outcomes for Indications Over Time",[],"2026-08-26T02:15:13.282904Z","2026-05-13T02:55:06.183765Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT03992625","Clinical Outcomes for Deep Brain Stimulation",[],"2026-08-26T02:18:42.501841Z","2026-05-13T02:55:06.181646Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":51,"content_modified":81},"NCT03664609","Deep Brain Stimulation (DBS) Retrospective Outcomes Study",[],"2026-05-13T02:55:06.173985Z",{"nct_id":83,"title":84,"phases":85,"status":13,"updated_at":86,"content_modified":87},"NCT00001208","Botulinum Toxin for the Treatment of Involuntary Movement Disorders",[],"2026-08-26T02:18:04.640417Z","2026-07-05T18:42:10.718856Z",{"nct_id":89,"title":90,"phases":91,"status":13,"updated_at":92,"content_modified":93},"NCT06585618","A Multicenter Pediatric Deep Brain Stimulation Registry",[],"2026-08-26T02:19:24.527214Z","2026-05-13T02:55:06.512961Z",{"nct_id":95,"title":96,"phases":97,"status":13,"updated_at":98,"content_modified":99},"NCT03042962","Brain Networks in Dystonia",[],"2026-08-26T02:18:54.586325Z","2026-05-13T02:55:06.106270Z",{"nct_id":101,"title":102,"phases":103,"status":13,"updated_at":104,"content_modified":105},"NCT00575081","Physiological Brain Atlas Development",[],"2026-08-26T02:17:41.695983Z","2026-05-13T02:55:06.038104Z",{"nct_id":107,"title":108,"phases":109,"status":13,"updated_at":110,"content_modified":111},"NCT05150093","Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor",[],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:28.846268Z",{"nct_id":113,"title":114,"phases":115,"status":13,"updated_at":116,"content_modified":117},"NCT05065151","Understanding Motivation in Parkinson's Patients Through Neurophysiology",[],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:26.743876Z",{"nct_id":119,"title":120,"phases":121,"status":13,"updated_at":122,"content_modified":123},"NCT05962489","Sleep-specific DBS Therapy in Parkinson's Disease",[],"2026-08-26T02:18:56.409949Z","2026-05-05T02:35:31.871577Z",{"nct_id":125,"title":126,"phases":127,"status":13,"updated_at":128,"content_modified":129},"NCT04286308","Cortical-Basal Ganglia Speech Networks",[],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:29.536601Z",{"nct_id":131,"title":132,"phases":133,"status":13,"updated_at":134,"content_modified":135},"NCT06848530","Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders",[],"2026-08-26T02:15:52.238965Z","2026-05-05T02:43:27.249573Z",{"nct_id":137,"title":138,"phases":139,"status":140,"updated_at":141,"content_modified":142},"NCT02553525","Effects of Stimulation Patterns of Deep Brain Stimulation",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:20.945539Z","2026-06-16T05:54:07.950506Z",{"nct_id":144,"title":145,"phases":146,"status":140,"updated_at":57,"content_modified":147},"NCT06912841","Deep Brain Stimulation (DBS) MatchMaker",[],"2026-06-16T05:54:07.840394Z",[],[150,154,158,161,164,167,170],{"state":151,"count":152,"slug":153},"Massachusetts",7,"massachusetts",{"state":155,"count":156,"slug":157},"California",3,"california",{"state":159,"count":156,"slug":160},"Florida","florida",{"state":162,"count":156,"slug":163},"Maryland","maryland",{"state":165,"count":156,"slug":166},"New York","new-york",{"state":168,"count":156,"slug":169},"Pennsylvania","pennsylvania",{"state":171,"count":156,"slug":172},"Texas","texas"]